BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23009386)

  • 1. Molecular insight into propeptide-protein interactions in cathepsins L and O.
    Reif MM; Mach L; Oostenbrink C
    Biochemistry; 2012 Oct; 51(43):8636-53. PubMed ID: 23009386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of human procathepsin K.
    LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
    Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.
    Coulombe R; Grochulski P; Sivaraman J; Ménard R; Mort JS; Cygler M
    EMBO J; 1996 Oct; 15(20):5492-503. PubMed ID: 8896443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of human procathepsin E: analysis of salt-bridge interactions between propeptide and enzyme segment.
    Azim MK; Zaidi ZH
    Biochem Biophys Res Commun; 1999 Nov; 264(3):825-32. PubMed ID: 10544016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide.
    McIntyre GF; Godbold GD; Erickson AH
    J Biol Chem; 1994 Jan; 269(1):567-72. PubMed ID: 8276852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
    Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
    J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocatalytic processing of recombinant human procathepsin L. Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in vitro.
    Ménard R; Carmona E; Takebe S; Dufour E; Plouffe C; Mason P; Mort JS
    J Biol Chem; 1998 Feb; 273(8):4478-84. PubMed ID: 9468501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-based structure in the proregion of procathepsin L is the recognition site for mannose phosphorylation.
    Cuozzo JW; Tao K; Wu QL; Young W; Sahagian GG
    J Biol Chem; 1995 Jun; 270(26):15611-9. PubMed ID: 7797559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of procathepsin L, a self-processing zymogen of guinea pig spermatozoa that acts on a cathepsin D assay substrate.
    McDonald JK; Emerick JM
    Arch Biochem Biophys; 1995 Nov; 323(2):409-22. PubMed ID: 7487106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells.
    Collins PR; Stack CM; O'Neill SM; Doyle S; Ryan T; Brennan GP; Mousley A; Stewart M; Maule AG; Dalton JP; Donnelly S
    J Biol Chem; 2004 Apr; 279(17):17038-46. PubMed ID: 14754899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein inhibitors form complexes with procathepsin L and augment cleavage of the propeptide.
    Majerle A; Jerala R
    Arch Biochem Biophys; 2003 Sep; 417(1):53-8. PubMed ID: 12921779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal glycosylation of procathepsin L due to N-terminal point mutations correlates with failure to sort to lysosomes.
    Chapman RL; Kane SE; Erickson AH
    J Biol Chem; 1997 Mar; 272(13):8808-16. PubMed ID: 9079717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation.
    Fairhead M; Kelly SM; van der Walle CF
    Biochem Biophys Res Commun; 2008 Feb; 366(3):862-7. PubMed ID: 18086562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of human procathepsin H.
    Hao Y; Purtha W; Cortesio C; Rui H; Gu Y; Chen H; Sickmier EA; Manzanillo P; Huang X
    PLoS One; 2018; 13(7):e0200374. PubMed ID: 30044821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of internal autoproteolytic cleavage sites within the prosegments of recombinant procathepsin B and procathepsin S. Contribution of a plausible unimolecular autoproteolytic event for the processing of zymogens belonging to the papain family.
    Quraishi O; Storer AC
    J Biol Chem; 2001 Mar; 276(11):8118-24. PubMed ID: 11115496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
    Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
    BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-step processing of procathepsin L in vitro.
    Ishidoh K; Kominami E
    FEBS Lett; 1994 Oct; 352(3):281-4. PubMed ID: 7925987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of the propeptide region in recombinant expression of active procathepsin L in Escherichia coli.
    Ogino T; Kaji T; Kawabata M; Satoh K; Tomoo K; Ishida T; Yamazaki H; Ishidoh K; Kominami E
    J Biochem; 1999 Jul; 126(1):78-83. PubMed ID: 10393323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.